OSTX Stock Analysis: Buy, Sell, or Hold?
OSTX - OS Therapies Incorporated
$1.59
0.01 (0.63%)
▲
5d:
-1.85%
30d:
+1.92%
90d:
-12.64%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When OSTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OSTX shows positive signals but monitor for confirmation. Market pricing in 5.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: OSTX shows positive signals but monitor for confirmation. Market pricing in 5.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.90
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.18
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSTX is currently trading at $1.59, which is considered oversold relative to its 30-day fair value range of $1.51 to $1.64. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.9) compared to its historical average (4.2). At these levels, the market is pricing in 5.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSTX is in a uptrend. Immediate support is located at $1.40, while resistance sits at $1.64.
Market Sentiment: OSTX scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.92 (+460.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OSTX is in a uptrend. Immediate support is located at $1.40, while resistance sits at $1.64.
Market Sentiment: OSTX scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.92 (+460.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.51 -
$1.64
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 460.9% below Wall St target ($8.92)
- NEUTRAL: Trading at premium valuation - market expects 5.1% growth which is achievable
- BULLISH: Bottoming setup score 68/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.51 -
$1.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.40
Resistance Level
$1.64
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.92
Wall Street Target
$8.92
(+460.9%)
Valuation Premium vs History
+5.1% premium
PE vs Historical
4.9 vs 4.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.1%
(market-implied from PE analysis)
1-Year Target
$1.67
(+5%)
2-Year Target
$1.76
(+11%)
3-Year Target
$1.85
(+16%)
3-Yr Target (if PE normalizes)
(PE: 5→4)
PE COMPRESSION
$1.58
(-1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 24, 2026 9:46 AM ET
Data refreshes hourly during market hours. Next update: 10:46 AM
Data refreshes hourly during market hours. Next update: 10:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$131 | 38 SELL |
